Lansoprazole Teva Pharma

Lansoprazole, the active ingredient in Lansoprazole Teva Pharma, is a proton pump inhibitor presented as a tablet for oral use. It irreversibly blocks the gastric proton pump, thereby reducing stomach acid production. The medication is indicated for the treatment of gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of combination therapy for Helicobacter pylori eradication in adult patients. It is formulated for systemic absorption and is commonly prescribed in standard doses under medical supervision.

GNH USA supplies Lansoprazole Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole, a proton pump inhibitor, reduces gastric acid production and is employed in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Erosive esophagitis: promotes healing of the damaged esophageal lining. - Peptic ulcer disease: supports ulcer healing and symptom relief. - Helicobacter pylori eradication: used as part of combination therapy to eradicate H. pylori infection.

Lansoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild pain in the head region. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with difficulty breathing or swelling. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat.

Before initiating lansoprazole therapy, consider the following precautions to ensure safe use. - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor hepatic function: use with caution in patients with liver disease. - Check magnesium levels: long‑term therapy can lead to hypomagnesemia. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Store at room temperature: keep in the original container, protect from moisture and heat.

Lansoprazole can alter the plasma concentrations of several co‑administered medicines; interaction severity varies.

Major Interactions (Avoid): - Clopidogrel: reduced activation leading to decreased antiplatelet effect. - Atazanavir: markedly decreased absorption and antiviral efficacy. - Ritonavir (and other HIV protease inhibitors): reduced plasma levels of the antiviral.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR requiring monitoring. - Methotrexate: increased exposure may enhance toxicity.